- Home
- BELFB vs IMNM Comparison
BELFB vs IMNM Comparison
Compare BELFB & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFB
- IMNM
- Stock Information
- Founded
- BELFB 1949
- IMNM 2006
- Country
- BELFB United States
- IMNM United States
- Employees
- BELFB N/A
- IMNM N/A
- Industry
- BELFB
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- BELFB
- IMNM Health Care
- Exchange
- BELFB Nasdaq
- IMNM Nasdaq
- Market Cap
- BELFB 865.9M
- IMNM 945.8M
- IPO Year
- BELFB N/A
- IMNM 2020
- Fundamental
- Price
- BELFB $128.22
- IMNM $9.66
- Analyst Decision
- BELFB Strong Buy
- IMNM Strong Buy
- Analyst Count
- BELFB 4
- IMNM 6
- Target Price
- BELFB $113.25
- IMNM $25.67
- AVG Volume (30 Days)
- BELFB 176.9K
- IMNM 759.7K
- Earning Date
- BELFB 07-24-2025
- IMNM 08-06-2025
- Dividend Yield
- BELFB 0.22%
- IMNM N/A
- EPS Growth
- BELFB N/A
- IMNM N/A
- EPS
- BELFB 4.05
- IMNM N/A
- Revenue
- BELFB $594,034,000.00
- IMNM $12,589,000.00
- Revenue This Year
- BELFB $21.74
- IMNM N/A
- Revenue Next Year
- BELFB $6.99
- IMNM $259.34
- P/E Ratio
- BELFB $31.46
- IMNM N/A
- Revenue Growth
- BELFB 6.08
- IMNM 16.74
- 52 Week Low
- BELFB $58.00
- IMNM $5.15
- 52 Week High
- BELFB $136.10
- IMNM $16.73
- Technical
- Relative Strength Index (RSI)
- BELFB 66.77
- IMNM 44.22
- Support Level
- BELFB $129.59
- IMNM $10.23
- Resistance Level
- BELFB $136.10
- IMNM $11.13
- Average True Range (ATR)
- BELFB 5.75
- IMNM 0.54
- MACD
- BELFB 0.13
- IMNM -0.19
- Stochastic Oscillator
- BELFB 76.21
- IMNM 8.45
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.